Iambic Therapeutics, Inc. research brief
CIK 1997038
Generated Nov. 17, 2026, 2:23 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: SAN DIEGO California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Sept. 9, 2026 · D · 0001997038-26-000002 · Source evidence
Reported offering amount: 66500000 USD. Reported amount sold: 65965000 USD.
- April 8, 2026 · D · 0001997038-26-000001 · Source evidence
Reported offering amount: 49999996 USD. Reported amount sold: 27769668 USD.
- Nov. 21, 2025 · D · 0001997038-25-000002 · Source evidence
Reported offering amount: 124999970 USD. Reported amount sold: 99269270 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Iambic Therapeutics, Inc. research brief,” CIK 1997038, retrieved Nov. 17, 2026, 2:23 p.m.. Cite the specific accessions used. No amounts have been summed.